Discover how Novo Nordisk's pipeline is being restructured to refocus its efforts on high-growth areas like diabetes and ...

The boss of the Wegovy firm linked its reduced guidance to the market for weight-loss treatments being ‘more competitive than ...

The bank's lead analyst recognizes the importance of getting in early with potentially game-changing drug development.

ADP private payrolls will be closely watched as the US shutdown stifling the flow of official data becomes the longest ever.

Novo Nordisk stock was rising after it posted quarterly earnings. The Danish drugmaker has gone from steady to chaotic. Its fight with Pfizer to acquire Metsera is getting more heated.

Arista Networks declined 8.9%. The cloud services provider posted better-than-expected third-quarter adjusted earnings as ...

Company cuts 9,000 jobs and lowers profit forecast as Wegovy sales slow. Q3 operating profit down 30% on competition ...

Arista Networks ( ANET 2.64%) slumped 11% in pre-market trading, even though earnings per share rose 25% after the company ...

The Danish pharmaceutical giant Novo Nordisk has struck an agreement with the Centers for Medicare & Medicaid Services (CMS) ...

Wegovy-maker Novo Nordisk presented new data on Wednesday showing its experimental weight-loss pill improved blood sugar ...

Novo Nordisk once dominated the weight-loss drug market with Wegovy. However, rising competition, particularly from Eli Lilly ...

LONDON () -Wegovy maker Novo Nordisk said on Wednesday that its executive vice president in charge of manufacturing was ...